SCHEMBL4779453

SCHEMBL4779453

Fc1c(N2CC3C(C2)C3N(Cc2ccccc2)Cc2ccccc2)cccc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.46
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ATM Q13315 1/20 0.39
HSD11B1 P28845 2/20 0.37
UBE2M P61081 1/20 0.37
DCUN1D1 Q96GG9 1/20 0.37
KMT2A Q03164 2/20 0.33
EPHX2 P34913 1/20 0.33
MEN1 O00255 1/20 0.33
CHRM4 P08173 1/20 0.32
C5AR1 P21730 2/20 0.32
RXRA P19793 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32
RBP4 P02753 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4781028 0.90 KDM4E (0.43) NOTUMKDM4EALDH1A1ATMHSD11B1
SCHEMBL4780332 0.87 CHRM4 (0.38) NOTUMKDM4EALDH1A1UBE2MDCUN1D1
SCHEMBL4778369 0.80 NOTUM (0.40) NOTUMKDM4EALDH1A1KMT2AMEN1
SCHEMBL4774338 0.80 DRD2 (0.32) KDM4EALDH1A1CHRM4DRD2DRD3
SCHEMBL4779536 0.80 DRD2 (0.32) KDM4EALDH1A1CHRM4DRD2DRD3
SCHEMBL4776176 0.77 FFAR4 (0.40) UBE2MDCUN1D1KMT2AMEN1
SCHEMBL4776370 0.77 CHRM4 (0.42) UBE2MDCUN1D1CHRM4DRD2DRD3
SCHEMBL4780326 0.76 CHRM4 (0.40) KDM4EALDH1A1UBE2MDCUN1D1CHRM4
SCHEMBL4774390 0.75 KDM4E (0.40) KDM4EALDH1A1ATMKMT2AMEN1
SCHEMBL4780839 0.74 SLC6A2 (0.44) NOTUMCHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008010061-A2 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-24 WO disclosed